GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (NYSE:PEN) » Definitions » Piotroski F-Score
中文

Penumbra (Penumbra) Piotroski F-Score : 8 (As of Apr. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Penumbra Piotroski F-Score?

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Penumbra has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Penumbra's Piotroski F-Score or its related term are showing as below:

PEN' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 8
Current: 8

During the past 12 years, the highest Piotroski F-Score of Penumbra was 8. The lowest was 2. And the median was 6.


Penumbra Piotroski F-Score Historical Data

The historical data trend for Penumbra's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Piotroski F-Score Chart

Penumbra Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 2.00 6.00 2.00 8.00

Penumbra Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 5.00 6.00 7.00 8.00

Competitive Comparison of Penumbra's Piotroski F-Score

For the Medical Devices subindustry, Penumbra's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Penumbra's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Penumbra's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 8.562 + 18.96 + 9.214 + 54.218 = $91 Mil.
Cash Flow from Operations was 13.129 + 17.099 + 30.844 + 36.261 = $97 Mil.
Revenue was 241.398 + 261.499 + 270.946 + 284.679 = $1,059 Mil.
Gross Profit was 151.072 + 166.861 + 177.718 + 186.992 = $683 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(1370.886 + 1395.298 + 1432.532 + 1468.377 + 1556.305) / 5 = $1444.6796 Mil.
Total Assets at the begining of this year (Dec22) was $1,371 Mil.
Long-Term Debt & Capital Lease Obligation was $221 Mil.
Total Current Assets was $915 Mil.
Total Current Liabilities was $151 Mil.
Net Income was 0.079 + -3.687 + -2.271 + 3.877 = $-2 Mil.

Revenue was 203.895 + 208.344 + 213.678 + 221.216 = $847 Mil.
Gross Profit was 127.418 + 134.035 + 135.327 + 138.427 = $535 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(1244.25 + 1301.573 + 1327.9 + 1321.601 + 1370.886) / 5 = $1313.242 Mil.
Total Assets at the begining of last year (Dec21) was $1,244 Mil.
Long-Term Debt & Capital Lease Obligation was $224 Mil.
Total Current Assets was $756 Mil.
Total Current Liabilities was $145 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Penumbra's current Net Income (TTM) was 91. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Penumbra's current Cash Flow from Operations (TTM) was 97. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=90.954/1370.886
=0.06634687

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-2.002/1244.25
=-0.001609

Penumbra's return on assets of this year was 0.06634687. Penumbra's return on assets of last year was -0.001609. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Penumbra's current Net Income (TTM) was 91. Penumbra's current Cash Flow from Operations (TTM) was 97. ==> 97 > 91 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=220.909/1444.6796
=0.15291211

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=223.82/1313.242
=0.17043317

Penumbra's gearing of this year was 0.15291211. Penumbra's gearing of last year was 0.17043317. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=915.402/151.144
=6.05648918

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=755.699/144.932
=5.2141625

Penumbra's current ratio of this year was 6.05648918. Penumbra's current ratio of last year was 5.2141625. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Penumbra's number of shares in issue this year was 39.315. Penumbra's number of shares in issue last year was 38.032. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=682.643/1058.522
=0.64490204

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=535.207/847.133
=0.63178627

Penumbra's gross margin of this year was 0.64490204. Penumbra's gross margin of last year was 0.63178627. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=1058.522/1370.886
=0.77214444

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=847.133/1244.25
=0.68083826

Penumbra's asset turnover of this year was 0.77214444. Penumbra's asset turnover of last year was 0.68083826. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+0+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Penumbra has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Penumbra  (NYSE:PEN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Penumbra Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Penumbra's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Penumbra (Penumbra) Business Description

Traded in Other Exchanges
Address
One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Executives
Harpreet Grewal director C/O VISTAPRINT USA, INCORPORATED, 100 HAYDEN AVE., LEXINGTON MA 02050
Surbhi Sarna director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Johanna Roberts officer: EVP, Gen. Counsel & Secretary PENUMBRA, INC., ONE PENUMBRA PLACE, ALAMEDA CA 94502
Bridget O'rourke director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Adam Elsesser director, officer: Chairman, CEO and President 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Don W. Kassing director 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Thomas Wilder director 2 MUSICK, IRVINE CA 92618
Arani Bose director, officer: Chief Innovator 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Lynn Rothman officer: EVP and Chief Business Officer 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
James Robert Pray officer: President, International 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Sridhar Kosaraju officer: CFO and Head of Strategy 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Maggie Yuen officer: Chief Financial Officer ONE PENUMBRA PLACE, ALAMEDA CA 94502
Lambert Shiu officer: Chief Accounting Officer ONE PENUMBRA PLACE, ALAMEDA CA 94502
Janet Leeds director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Robert D. Evans officer: EVP, Gen. Counsel & Secretary ONE PENUMBRA PLACE, 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502